The role of gabapentin in treating diseases with cutaneous manifestations and pain
- 3 June 2003
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 42 (6) , 491-495
- https://doi.org/10.1046/j.1365-4362.2003.01831.x
Abstract
Background Gabapentin was first approved by the FDA in 1993 as an add‐on treatment for partial epileptic seizures. In May of 2002, it was approved as treatment for post‐herpetic neuralgia by the Food...Keywords
This publication has 49 references indexed in Scilit:
- Drug points: Gabapentin induced cholestasisBMJ, 2002
- Gabapentin - a promising treatment in glossodyniaClinical and Experimental Dermatology, 2002
- Gabapentin-Induced Anorgasmia in WomenAmerican Journal of Psychiatry, 2002
- Concerns with Antiepileptic Drug Initiation: Safety, Tolerability, and EfficacyEpilepsia, 2001
- Effects of gabapentin in acute inflammatory pain in humansRegional Anesthesia & Pain Medicine, 2001
- A Case of Sustained Massive Gabapentin Overdose Without Serious Side EffectsTherapeutic Drug Monitoring, 1999
- Gabapentin treatment for brachioradial pruritusJournal of the European Academy of Dermatology and Venereology, 1999
- Use of Gabapentin in a Case of Facial NeuritisAnesthesia & Analgesia, 1997
- Reflex sympathetic dystrophy treated with gabapentinArchives of Physical Medicine and Rehabilitation, 1997
- The DyniasSeminars in Neurology, 1996